Pau Sancho-Bru
Grupo de investigación
- Plasticidad y reparación tisular en enfermedades hepáticas Group leader (R4)
Publicaciones destacadas
-
Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease
Autores:Referencia: Journal Of Hepatology 2023. -
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Autores:Referencia: Journal Of Hepatology 2023. -
Ductular Reaction Promotes Intrahepatic Angiogenesis Via Slit2-Robo1 Signaling
Autores:Referencia: Hepatology 2022. -
Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells
Autores:Referencia: Nature Protocols 2021. -
Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
Autores:Referencia: Jhep Rep 2021. -
Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis
Autores:Referencia: Hepatology 2019. -
Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis
Autores:Referencia: Cell Stem Cell 2018.
Proyectos destacados
-
Patient-derived liver biopsy-organoids for personalized medicine in NAFLD (Non-Alcoholic Fatty Liver Disease): towards real time assessment of drug response (B-ORG)
Investigador/a principal: Pau Sancho BruFinanciador: Ministerio de Ciencia e InnovaciónCódigo: IBEC_ProyectCompl22Duración: 13/04/2023 - 31/12/2024 -
Dissecting the role of the 14q32 region in hepatoblastoma Hblast14
Investigador/a principal: Pau Sancho BruFinanciador: Worldwide Cancer ResearchCódigo: INT_WWCR_22Duración: 01/04/2023 - 31/03/2026 -
Off the shelf hepatic stellate cells for liver disease modeling and drug screening
Investigador/a principal: Pau Sancho BruFinanciador: Instituto de Salud Carlos IIICódigo: FIS_DTS22Duración: 01/01/2023 - 31/12/2025 -
Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH transition to inform early prevention and treatment strategies. (Halt-RONIN)
Investigador/a principal: Pau Sancho BruFinanciador: European CommissionDuración: 01/12/2022 - 30/11/2026 -
Mechanisms of impaired liver regeneration in alcoholic liver disease: drivers and therapeutic targets
Investigador/a principal: Pau Sancho BruFinanciador: Instituto de Salud Carlos IIICódigo: PI20/00765Duración: 01/01/2021 - 31/12/2023